Zajímavosti o včelím jedu a jeho analýze - literatura

¹

López-Incera, A., Nouvian, M., Ried, K., Müller, T. & Briegel, H. J. Honeybee communication during collective defence is shaped by predation. BMC Biology 19, (2021) doi:10.1186/s12915-021-01028-x.

²

Nouvian, M., Reinhard, J. & Giurfa, M. The defensive response of the honeybee Apis mellifera. Journal of Experimental Biology 219, 3505-3517 (2016) doi:10.1242/jeb.143016.

³

Golden, D. B. K. Insect Sting Anaphylaxis. Immunology and Allergy Clinics of North America 27, 261-272 (2007) doi:10.1016/j.iac.2007.03.008.

⁴

Fitzgerald, K. T. & Flood, A. A. Hymenoptera Stings. Clinical Techniques in Small Animal Practice 21, 194-204 (2006) doi:10.1053/j.ctsap.2006.10.002.

⁵

Wehbe, R. et al. Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules 24, (2019) doi:10.3390/molecules24162997.

⁶

Ziai, M. R., Russek, S., Wang, H. -C., Beer, B. & Blume, A. J. Mast Cell Degranulating Peptide: A Multi-functional Neurotoxin. Journal of Pharmacy and Pharmacology 42, 457-461 (1990) doi:10.1111/j.2042-7158.1990.tb06595.x.

⁷

Ullah, A. et al. Pharmacological properties and therapeutic potential of honey bee venom. Saudi Pharmaceutical Journal 31, 96-109 (2023) doi:10.1016/j.jsps.2022.11.008.

⁸

Van Vaerenbergh, M., Debyser, G., Devreese, B. & de Graaf, D. C. Exploring the hidden honeybee (Apis mellifera) venom proteome by integrating a combinatorial peptide ligand library approach with FTMS. Journal of Proteomics 99, 169-178 (2014) doi:10.1016/j.jprot.2013.04.039.

⁹

Yaacoub, C., Wehbe, R., Roufayel, R., Fajloun, Z. & Coutard, B. Bee Venom and Its Two Main Components—Melittin and Phospholipase A2—As Promising Antiviral Drug Candidates. Pathogens 12, (2023) doi:10.3390/pathogens12111354.

¹⁰

Raghuraman, H. & Chattopadhyay, A. Melittin: a Membrane-active Peptide with Diverse Functions. Bioscience Reports 27, 189-223 (2007) doi:10.1007/s10540-006-9030-z.

¹¹

Chen, J., Guan, S. -M., Sun, W. & Fu, H. Melittin, the Major Pain-Producing Substance of Bee Venom. Neuroscience Bulletin 32, 265-272 (2016) doi:10.1007/s12264-016-0024-y.

¹²

Lee, M. -T., Sun, T. -L., Hung, W. -C. & Huang, H. W. Process of inducing pores in membranes by melittin. Proceedings of the National Academy of Sciences 110, 14243-14248 (2013) doi:10.1073/pnas.1307010110.

¹³

Zhang, H. -Q., Sun, C., Xu, N. & Liu, W. The current landscape of the antimicrobial peptide melittin and its therapeutic potential. Frontiers in Immunology 15, (2024) doi:10.3389/fimmu.2024.1326033.

¹⁴

Gu, H., Han, S. M. & Park, K. -K. Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease. Toxins 12, (2020) doi:10.3390/toxins12030195.

¹⁵

Bindlish, A. & Sawal, A. Bee Sting Venom as a Viable Therapy for Breast Cancer: A Review Article. Cureus (2024) doi:10.7759/cureus.54855.

¹⁶

Pucca, M. B. et al. Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy. Frontiers in Immunology 10, (2019) doi:10.3389/fimmu.2019.02090.

¹⁷

Banks, B. E. C., Dempsey, C. E., Vernon, C. A., Warner, J. A. & Yamey, J. Anti‐inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo. British Journal of Pharmacology 99, 350-354 (1990) doi:10.1111/j.1476-5381.1990.tb14707.x.

¹⁸

Abdela, N. & Jilo, K. Bee Venom and Its Therapeutic Values: A Review. Advances in Life Science and Technology 44, 18-22 (2016).

¹⁹

Sadek, K. M. et al. Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review. Frontiers in Pharmacology 15, (2024) doi:10.3389/fphar.2024.1412245.

²⁰

Elieh Ali Komi, D., Shafaghat, F. & Zwiener, R. D. Immunology of Bee Venom. 54, 386-396 (2018) doi:10.1007/s12016-017-8597-4.

²¹

Otręba, M., Marek, Ł., Tyczyńska, N., Stojko, J. & Rzepecka-Stojko, A. Bee Venom, Honey, and Royal Jelly in the Treatment of Bacterial Infections of the Oral Cavity: A Review. Life 11, (2021) doi:10.3390/life11121311.

²²

Bava, R. et al. Therapeutic Use of Bee Venom and Potential Applications in Veterinary Medicine. Veterinary Sciences 10, (2023) doi:10.3390/vetsci10020119.

²³

Stevanović, J. et al. Bee-Inspired Healing: Apitherapy in Veterinary Medicine for Maintenance and Improvement Animal Health and Well-Being. Pharmaceuticals 17, (2024) doi:10.3390/ph17081050.

²⁴

Kim, S. H. et al. Therapeutic Effect of Injection-Acupuncture with Bee-Venom (Apitoxin) in Cases of Canine Otitis Externa. J Vet Clin 25, 159-164. (2008).

²⁵

Vick, J. A., Warren, G. B. & Brooks, R. B. The effect of treatment with whole bee venom on cage activity and plasma cortisol levels in the arthritic dog. Inflammation 1, 167-174 (1976) doi:10.1007/BF00917527.

²⁶

Kim, D. H. et al. Acupuncture Treatment in a Case with Equine Laminitis. J Vet Clin 23, 6-8 (2006).

²⁷

Lee, J. A. et al. Bee venom acupuncture for rheumatoid arthritis: a systematic review protocol. BMJ Open 4, (2014) doi:10.1136/bmjopen-2013-004602.

²⁸

Stela, M., Cichon, N., Spławska, A., Szyposzynska, M. & Bijak, M. Therapeutic Potential and Mechanisms of Bee Venom Therapy: A Comprehensive Review of Apitoxin Applications and Safety Enhancement Strategies. Pharmaceuticals 17, (2024) doi:10.3390/ph17091211.

²⁹

Kurek-Górecka, A., Komosinska-Vassev, K., Rzepecka-Stojko, A. & Olczyk, P. Bee Venom in Wound Healing. Molecules 26, (2021) doi:10.3390/molecules26010148.

³⁰

Park, H. J. et al. Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF‐κB through interaction with the p50 subunit. 50, 3504-3515 (2004) doi:10.1002/art.20626.

³¹

Kim, W. -H. et al. Anti-Inflammatory Effect of Melittin on Porphyromonas Gingivalis LPS-Stimulated Human Keratinocytes. Molecules 23, (2018) doi:10.3390/molecules23020332.

³²

An, H. ‐J. et al. Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro. British Journal of Pharmacology 175, 4310-4324 (2018) doi:10.1111/bph.14487.

³³

Alvarez-Fischer, D. et al. Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model. PLoS ONE 8, (2013) doi:10.1371/journal.pone.0061700.

³⁴

Ye, M. et al. Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease. Journal of Neuroinflammation 13, (2016) doi:10.1186/s12974-016-0476-z.

³⁵

Jung, G. B. et al. Anti-cancer effect of bee venom on human MDA-MB-231 breast cancer cells using Raman spectroscopy. Biomedical Optics Express 9, (2018) doi:10.1364/BOE.9.005703.

³⁶

Wang, C. et al. Melittin, a Major Component of Bee Venom, Sensitizes Human Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis by Activating CaMKII-TAK1-JNK/p38 and Inhibiting IκBα Kinase-NFκB. Journal of Biological Chemistry 284, 3804-3813 (2009) doi:10.1074/jbc.M807191200.

³⁷

Park, M. H. et al. Anti‐cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF‐κB. The Prostate 71, 801-812 (2011) doi:10.1002/pros.21296.

³⁸

Lazarev, V. N. et al. Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. International Journal of Antimicrobial Agents 19, 133-137 (2002) doi:10.1016/S0924-8579(01)00479-4.

³⁹

Lubke, L. L. & Garon, C. F. The Antimicrobial Agent Melittin Exhibits Powerful In Vitro Inhibitory Effects on the Lyme Disease Spirochete. Clinical Infectious Diseases 25, S48-S51 (1997) doi:10.1086/516165.

⁴⁰

Kasozi, K. I. et al. Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections. Frontiers in Public Health 8, (2020) doi:10.3389/fpubh.2020.594458.

⁴¹

El Mehdi, I. et al. Analytical methods for honeybee venom characterization. 13, 154-160 (2022) doi:10.4103/japtr.japtr_166_21.

⁴²

Choi, J. H. et al. Melittin, a honeybee venom-derived antimicrobial peptide, may target methicillin-resistant Staphylococcus aureus. Molecular Medicine Reports 12, 6483-6490 (2015) doi:10.3892/mmr.2015.4275.